Accelerate Diagnostics
3950 S. Country Club Road
Suite 470
Tucson
Arizona
85714
United States
Tel: 520-365-3100
Fax: 520-269-6580
Website: http://acceleratediagnostics.com/
Email: contact@axdx.com
134 articles about Accelerate Diagnostics
-
Accelerate Diagnostics Schedules Call to Review Second Quarter 2020 Results
7/16/2020
Accelerate Diagnostics, Inc. announced today that management will host a conference call on Thursday, August 6, 2020 at 4:30 p.m. Eastern Time to review 2020 second quarter financial results. To listen
-
Accelerate Diagnostics Announces First Quarter Financial Results and Provides COVID-19 Business Updates
5/7/2020
Accelerate Diagnostics, Inc., announced financial results for the quarter ending March 31, 2020 and provided a business update regarding the impact of the ongoing COVID-19 pandemic on the Company's operations.
-
Accelerate Diagnostics Announces Preliminary First Quarter Financial Results and Provides COVID-19 Business Updates; Schedules First Quarter 2020 Financial Results Conference Call for May 7, 2020
4/15/2020
Accelerate Diagnostics, Inc. (NASDAQ: AXDX), today announced preliminary financial results for the quarter ending March 31, 2020 and provided a business update regarding the impact of the ongoing COVID-19 pandemic on the Company's operations. The Company also announced that it will report full results for the quarter ending March 31
-
Accelerate Diagnostics and BioCheck Announce Commercial Supply and Collaboration Agreement to Distribute MS-FAST Chemiluminescence Immunoassay Analyzer and SARS-CoV-2 Antibody Tests
4/15/2020
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) and BioCheck, Inc., a privately-held San Francisco -based company focused on in vitro diagnostics, today announced that they have entered into a commercial supply and collaboration agreement. Under the agreement, Accelerate Diagnostics will distribute the BioCheck MS-FAST, a fully-automat
-
Accelerate Diagnostics Reports Fourth Quarter 2019 Financial Results
2/27/2020
Accelerate Diagnostics, Inc. announced financial results for the fourth quarter and full year ended December 31, 2019..
-
Accelerate Diagnostics schedules call to review 2019 fourth quarter and full-year results
2/18/2020
TUCSON, Ariz. , Feb. 18, 2020 /PRNewswire/ -- Accelerate Diagnostics, Inc. announced today that management will host a conference call on Thursday, February 27, 2020 at 4:30 p.m. Eastern Time to review 2019 fourth quarter and full-year financial results. To listen to the audio webcast online, visit ir.axdx.com . A replay of the au
-
Accelerate Diagnostics Announces Preliminary Fourth Quarter and Full-Year 2019 Financial Results
1/13/2020
Accelerate Diagnostics, Inc., announced preliminary financial results for the quarter and year ending December 31, 2019.
-
Accelerate Diagnostics to Participate in 38th Annual J.P. Morgan Healthcare Conference in San Francisco on January 15, 2020
1/3/2020
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that the company is scheduled to present at the 38th Annual J.P. Morgan Healthcare Conference in San Francisco on January 15, 2020, at 11:30 a.m. Pacific Time.
-
Accelerate Diagnostics to Participate in 31st Annual Piper Jaffray Healthcare Conference in New York on December 4, 2019
12/4/2019
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that Larry Mehren, chief executive officer, will participate in a 25-minute question and answer session at the 31st Annual Piper Jaffray Healthcare Conference in New York on December 4, 2019 at 3:30 p.m. Eastern Time.
-
Accelerate Diagnostics Announces Executive Transition: Lawrence Mehren to Retire as Chief Executive Officer; Jack Phillips Appointed as Successor
12/4/2019
Accelerate Diagnostics, Inc. (NASDAQ:AXDX) today announced that Lawrence Mehren will retire from the company. Jack Phillips, the company's Chief Operating Officer, has been unanimously appointed by the board to the position, effective February 1, 2020
-
Accelerate Diagnostics Appoints Louise Francesconi to its Board of Directors
12/2/2019
Accelerate Diagnostics, Inc. announced that Louise Francesconi has been appointed to the company's Board of Directors.
-
Accelerate Diagnostics Reports Third Quarter 2019 Financial Results
11/7/2019
Accelerate Diagnostics, Inc. announced financial results for the third quarter ended September 30, 2019.
-
Accelerate Diagnostics Appoints Roland Diggelmann to its Board of Directors
11/4/2019
Accelerate Diagnostics, Inc. (Nasdaq: AXDX) today announced that Roland Diggelmann has been appointed to its Board of Directors.
-
Accelerate Diagnostics Schedules Call to Review Third Quarter 2019 Results
10/17/2019
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) announced today that it will report financial results for the third quarter of 2019 after the market close on Thursday, November 7, 2019.
-
Studies Confirm Rapid Phenotypic Susceptibility Results Enable Earlier Antimicrobial Intervention and Better Patient Outcomes
10/3/2019
From IDWeek™, the annual meeting of the Infectious Diseases Society of America (IDSA) held in Washington, DC October 2 - 6.
-
Accelerate Diagnostics Highlights Clinical Endpoints Achieved Across Mayo Clinic/UCLA, University of Iowa, and UAMS Studies
9/18/2019
Accelerate Diagnostics, Inc. (NASDAQ: AXDX) today announced the release of positive results from three clinical studies on the Accelerate Pheno™ system that will be presented at IDWeek™ 2019.
-
Accelerate Diagnostics Names Jack Phillips Chief Operating Officer
8/8/2019
Mr. Phillips joins Accelerate from Roche Diagnostics, the world's leading diagnostics company.
-
Accelerate Diagnostics Reports Second Quarter 2019 Financial Results
8/8/2019
Accelerate Diagnostics, Inc. announced financial results for the second quarter ended June 30, 2019.
-
Accelerate Diagnostics Expands Antimicrobials in New CE-Marked Accelerate PhenoTest™ BC kit
8/2/2019
Accelerate Diagnostics, Inc. announced the release and CE marking of its latest Accelerate PhenoTest™ BC kit, declaring conformity to the European Directive 98/79/EC on in vitro diagnostic medical devices.
-
Accelerate Diagnostics Schedules Call to Review Second Quarter 2019 Results
7/8/2019
The company's management will host a conference call at 4:30 p.m. ET that same day to review the results.